Primary liver cancer is the third cause of cancer death worldwide with 906,000 new cases and 830,000 deaths. Of these, 75-85% of patients are hepatocellular carcinoma (HCC), while the remaining 15-25% ...
Acoustic droplet vapourisation (ADV) and phase‐change contrast agents (PCCAs) represent a promising frontier in biomedical ultrasound technology. By employing focused ultrasound, liquid ...